These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved? Restini CBA; Fink GD; Watts SW Pharmacol Res; 2021 Jan; 163():105273. PubMed ID: 33197599 [TBL] [Abstract][Full Text] [Related]
3. Trimethylamine But Not Trimethylamine Oxide Increases With Age in Rat Plasma and Affects Smooth Muscle Cells Viability. Jaworska K; Konop M; Hutsch T; Perlejewski K; Radkowski M; Grochowska M; Bielak-Zmijewska A; Mosieniak G; Sikora E; Ufnal M J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1276-1283. PubMed ID: 31411319 [TBL] [Abstract][Full Text] [Related]
4. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals. Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382 [TBL] [Abstract][Full Text] [Related]
5. Contractile effect of trimethylamine and trimethylamine-n-oxide on isolated human umbilical arteries. Ongun MC; Orgul G; Celik C; Bariskaner H J Obstet Gynaecol Res; 2023 Jul; 49(7):1736-1742. PubMed ID: 37045561 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331 [TBL] [Abstract][Full Text] [Related]
7. Increased circulating trimethylamine N-oxide contributes to endothelial dysfunction in a rat model of chronic kidney disease. Li T; Gua C; Wu B; Chen Y Biochem Biophys Res Commun; 2018 Jan; 495(2):2071-2077. PubMed ID: 29247650 [TBL] [Abstract][Full Text] [Related]
8. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study. Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906 [TBL] [Abstract][Full Text] [Related]
9. Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study. Jomard A; Liberale L; Doytcheva P; Reiner MF; Müller D; Visentin M; Bueter M; Lüscher TF; Vettor R; Lutz TA; Camici GG; Osto E Sci Rep; 2022 May; 12(1):8664. PubMed ID: 35606406 [TBL] [Abstract][Full Text] [Related]
10. TMAO, a seafood-derived molecule, produces diuresis and reduces mortality in heart failure rats. Gawrys-Kopczynska M; Konop M; Maksymiuk K; Kraszewska K; Derzsi L; Sozanski K; Holyst R; Pilz M; Samborowska E; Dobrowolski L; Jaworska K; Mogilnicka I; Ufnal M Elife; 2020 Jun; 9():. PubMed ID: 32510330 [TBL] [Abstract][Full Text] [Related]
11. Trimethylamine-N-oxide Specifically Impairs Endothelium-Derived Hyperpolarizing Factor-Type Relaxation in Rat Femoral Artery. Matsumoto T; Kojima M; Takayanagi K; Taguchi K; Kobayashi T Biol Pharm Bull; 2020; 43(3):569-573. PubMed ID: 32115516 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Zhang W; Miikeda A; Zuckerman J; Jia X; Charugundla S; Zhou Z; Kaczor-Urbanowicz KE; Magyar C; Guo F; Wang Z; Pellegrini M; Hazen SL; Nicholas SB; Lusis AJ; Shih DM Sci Rep; 2021 Jan; 11(1):518. PubMed ID: 33436815 [TBL] [Abstract][Full Text] [Related]
13. The role of gut-dependent molecule trimethylamine N-oxide as a novel target for the treatment of chronic kidney disease. Pan S; Zhao D; Duan S; Chen X Int Urol Nephrol; 2023 Jul; 55(7):1747-1756. PubMed ID: 36797553 [TBL] [Abstract][Full Text] [Related]
14. Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria. Makrecka-Kuka M; Volska K; Antone U; Vilskersts R; Grinberga S; Bandere D; Liepinsh E; Dambrova M Toxicol Lett; 2017 Feb; 267():32-38. PubMed ID: 28049038 [TBL] [Abstract][Full Text] [Related]
15. Data on cardiac and vascular functionality in Videja M; Vilskersts R; Sevostjanovs E; Liepinsh E; Dambrova M Data Brief; 2023 Feb; 46():108890. PubMed ID: 36687149 [TBL] [Abstract][Full Text] [Related]
16. Trimethylamine-N-Oxide (TMAO)-Induced Impairment of Cardiomyocyte Function and the Protective Role of Urolithin B-Glucuronide. Savi M; Bocchi L; Bresciani L; Falco A; Quaini F; Mena P; Brighenti F; Crozier A; Stilli D; Del Rio D Molecules; 2018 Mar; 23(3):. PubMed ID: 29494535 [TBL] [Abstract][Full Text] [Related]
17. [Trimethylamine-N-oxide and cardiovascular events in chronic kidney disease]. Dai Q; Zhang H; Liu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1294-1299. PubMed ID: 31919326 [TBL] [Abstract][Full Text] [Related]